The raised guidance and strong SHOP operating metrics (14.6% same-store NOI growth, 34.9% margin) signal accelerating earnings power from the portfolio shift toward higher-margin managed senior housing. Watch for continued investment pipeline conversion and further margin expansion in SHOP as the portfolio scales toward 50% SHOP concentration by end of 2027.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $20.35entry
- T+1 · 13d ago +3.64%α +1.98% · $21.09
- T+5 · 7d ago +4.77%α +5.35% · $21.32
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Sabra Health Care REIT reported Q3 2026 Normalized AFFO of $0.41 per share, above the Street consensus of $0.39, and raised its full-year 2026 Normalized AFFO guidance midpoint to $1.605 from the prior $1.57. Same-store SHOP Cash NOI grew 14.6% year-over-year, and the company closed $222.8 million in SHOP acquisitions during the quarter. A $104.6 million provision for loan losses in the nine-month period reflects a large reserve build that weighed on GAAP net income.
Key Financial Metrics
Key Facts
- Q3 2026 Normalized AFFO per share of $0.41 vs. consensus $0.39 (beat).
- Full-year 2026 Normalized AFFO guidance raised to $1.600-$1.610 from prior $1.55-$1.59.
- Same-store SHOP Cash NOI grew 14.6% year-over-year in Q3 2026.
- Closed $222.8 million in SHOP acquisitions in Q3; year-to-date investments total $747.2 million at 8.0% estimated yield.
- Net Debt to Adjusted EBITDA improved to 4.54x from 5.00x at year-end 2025.
- Quarterly dividend declared at $0.30 per share.
- Nine-month provision for loan losses of $104.6 million (including a large reserve build).
Financial Impact
Normalized AFFO beat consensus by ~5.1% ($0.41 vs $0.39); guidance raised by ~2.2% at midpoint ($1.605 vs $1.57).
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Skilled Nursing/Transitional Care | Not reported | Not reported |
| Senior Housing - Leased | Not reported | Not reported |
| SHOP | $143.2M | +55.6% |
| Specialty Hospitals and Other | Not reported | Not reported |
Risk Factors
- Large $104.6 million provision for loan losses in the nine-month period signals credit stress in the loan book.
- Dilution from ATM forward sales (15.0 million shares outstanding under forward agreements at $19.53) could weigh on per-share growth.
- Skilled nursing tenant concentration (Ensign Group at 8.4% of NOI) and upcoming lease maturities create re-leasing risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001492298-26-000032 |
| Document: sbraex9912026q3.htm | 0001492298-26-000032 |
| Document: sbraex9922026q3-final.htm | 0001492298-26-000032 |
| Document: sbraex9942026q3_final.htm | 0001492298-26-000032 |
| Document: sbra-20261102.htm | 0001492298-26-000032 |
| Document: 0001492298-26-000032-index-headers.html | 0001492298-26-000032 |
| Document: 0001492298-26-000032-index.html | 0001492298-26-000032 |
| 8-K Data (Synthetic) | 0001492298-26-000032 |
Track record
4 reports on SBRA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $20.97 Now $20.35 −2.96% settles Nov 18
- Nov 2, 202614d ago 8-K Bullish 6/10 Viewing Entry $20.35 to $21.32 Now $20.35 +0.00% ▲ +4.77% +5.35% vs SPY
- Jul 21, 202616w ago 8-K Bullish 7/10 Entry $22.04 to $22.39 Now $20.35 −7.67% ▲ +1.59% +2.82% vs SPY
- Apr 24, 202629w ago DEFA14A Neutral 3/10 Entry $20.09 to $20.66 Now $20.35 +1.29% ▲ +2.84% +1.93% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers